Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

FDA approves new robotic surgery device

Senhance System backed for colorectal and gynaecological operations

US Food and Drug Administration (FDA)

US regulators have approved a new robotic surgery device for use in colorectal and gynaecological operations.

TransEnterix Surgical’s computer-assisted surgical Senhance System allows surgeons to sit at a console unit or cockpit that provides a 3-D high-definition view of the surgical field.

The three robotic arms they control are equipped with surgical instruments for visualisation and endoscopic manipulation of tissue, including through grasping and suturing.

Robotically-assisted surgical devices (RASDs), although not actually robots because they still require direct human control, can facilitate minimally invasive surgery and assist with complex tasks in confined areas of the body.

Binita Ashar, director of the Division of Surgical Devices in the FDA’s Center for Devices and Radiological Health, said: “Minimally invasive surgery helps reduce pain, scarring and recovery time after surgery.

“RASD technology is a specialised innovation in minimally invasive surgery designed to enhance the surgeon’s access and visualization within confined operative sites.”

RASD enables a surgeon to use computer and software technology to control and move surgical instruments through one or more tiny incisions in the patient’s body.

The FDA approved TransEnterix’s system for use in adults by trained physicians after the regulator concluded it was substantially equivalent for gynaecological and colorectal procedures to the da Vinci Si IS3000 device, which was launched in 2009 by Intuitive Surgical.

17th October 2017

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...
Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...

Infographics